Skip to main content

JANUS HENDERSON GROUP PLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1274173 LONDON, X0

Position in APGE

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$198,691,364
+$43,006,015 QoQ
Shares Held
2,360,596
+14.4% QoQ
Ownership
3.12%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 0% Shared 96% None 4%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. APGE ranks #18 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $198,691,364 2,360,596
2025-12-31 $155,685,349 2,062,604
2025-09-30 $19,307,905 485,978
2025-06-30 $22,119,810 509,321
2025-03-31 $67,017,600 1,793,833
2024-12-31 $51,420,029 1,135,100
2024-09-30 $27,581,778 469,557
2024-06-30 $448,590 11,400
2024-03-31 $406,009 6,110
2023-12-31 $13,402,426 479,686
2023-09-30 $12,747,943 598,495